AIRMO | $5,880,175 | (Apr 14, 2026)
Qoro | $750,000 | (Apr 14, 2026)
Remission Medical | Undisclosed Amount | (Apr 14, 2026)
Certified by Founder
Lodge
eGenesis, Inc.
start up
United States
- Cambridge, MA
- 04/09/2024
- Series B
- $191,000,000
eGenesis is revolutionizing the field of transplantation with an unparalleled, multiplexed gene editing platform for the development of human-compatible organs, tissues and cells. Harnessing the latest gene-editing techniques, eGenesis’ mission is to solve the global organ shortage crisis by developing a scalable alternative to allotransplantation.
eGenesis is reinvigorating the field of xenotransplantation by addressing the key virology and immunology hurdles that have prevented its advancement to date, and is developing commercially-viable products to save and improve the lives of patients who are waiting for an organ transplant.
- Industry Biotechnology Research
- Website https://egenesisbio.com/
- LinkedIn https://www.linkedin.com/company/egenesisbio/
Pixel Photonics | $5,880,875 | (Apr 14, 2026)
Critical Loop | $26,000,000 | (Apr 14, 2026)
Blocks | $6,000,000 | (Apr 14, 2026)
Slate Auto | $650,000,000 | (Apr 14, 2026)
Citra Space Corporation | $15,000,000 | (Apr 14, 2026)
Flashpass | $4,250,000 | (Apr 14, 2026)
TeiaCare & Ancelia: AI for Care Homes | $8,184,645 | (Apr 10, 2026)
Sigma Automate | $2,750,000 | (Apr 10, 2026)
Felix(1) | $1,700,000 | (Apr 10, 2026)